National Comprehensive Cancer Network



About NCCN

Kidney/Testicular Cancers Panel - Disclosures as of 4/16/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Neeraj Agarwal, MD

Dendreon Corporation;
GlaxoSmithKline

Exelixis Inc.;
Medivation

None

None

2/19/2014

Clair Beard, MD

None

None

None

None

5/3/2013

Sam Bhayani, MD

None

None

None

None

8/18/2013

Graeme B. Bolger, MD

Eli Lilly and Company;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Altor Biosciences;
Medivation Inc.,;
Seattle Genetics;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

GlaxoSmithKline

None

None

3/5/2013

Sam S. Chang, MD

None

None

None

None

8/13/2013

Toni K. Choueiri, MD

None

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
AVEO Pharmaceuticals, Inc.;
Pfizer Inc.

None

None

12/20/2013

Ithaar H. Derweesh, MD

       

Pending

Mary Dwyer, MS

None

None

None

None

3/7/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Shilpa Gupta, MD

None

None

None

None

8/14/2013

Steven L. Hancock, MD

None

None

None

None

6/19/2013

Eric Jonasch, MD

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

1/14/2014

Jenny J Kim, MD

None

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Aveo;
GalaxoSmithKline

None

None

2/28/2013

Rashmi Kumar, PhD

None

None

None

None

5/28/2013

Timothy M. Kuzel, MD

Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
GlaxoSmithKline;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Alton Pharmaceuticals;
ARgos Therapeutics;
Aveo;
Biovex, Inc/Amgen

Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Elorac;
Prometheus Laboratories;
Pfizer Inc.

None

None

7/3/2013

Elaine T. Lam, MD

Bristol-Myers Squibb Company;
Exelixis Inc.;
Genentech, Inc.;
Argos Therapeutics

Exelixis Inc.

None

None

8/13/2013

Clayton Lau, MD

None

Covidien AG;
Intuitive Surgical, Inc.

None

None

10/1/2012

Ellis G. Levine, MD

TRACON Pharmaceuticals

None

UpToDate

None

8/14/2013

Daniel W. Lin, MD

None

None

None

None

8/15/2013

Joan S. McClure, MS

None

None

None

None

8/13/2013

M. Dror Michaelson, MD, PhD

Eisai Inc.;
Millennium Pharmaceuticals, Inc.;
Pfizer Inc.

Millennium Pharmaceuticals, Inc.;
Pfizer Inc.

None

None

8/6/2013

Robert J. Motzer, MD

Bristol-Myers Squibb Company;
Eisai Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

Merck & Co., Inc.;
Aveo Oncology;
Pfizer Inc.

None

None

6/10/2013

Thomas Olencki, DO

Bristol-Myers Squibb Company;
Genentech, Inc.;
Aveo

Genentech, Inc.

None

None

3/4/2013

Roberto Pili, MD

Pfizer Inc.

Genentech, Inc.;
Pfizer Inc.

None

Active Biotech AB;
Regeneron;
Pfizer Inc.

4/12/2013

Elizabeth R. Plimack, MD, MS

Bristol-Myers Squibb Company;
Dendreon Corporation;
GlaxoSmithKline;
Merck & Co., Inc.;
Acceleron

Dendreon Corporation;
GlaxoSmithKline;
Astellas

None

None

8/3/2013

Edward N. Rampersaud, MD

None

None

None

None

7/24/2013

Bruce G. Redman, DO

None

None

None

None

8/13/2013

Charles J. Ryan, MD

None

None

None

None

6/10/2011

Joel Sheinfeld, MD

None

None

None

None

8/7/2012

Kanishka Sircar, MD

None

None

None

None

12/13/2013

Bradley G. Somer, MD

None

None

None

None

4/4/2013

Sarika Trikha

None

None

None

None

8/13/2013

Jue Wang, MD

Celgene Corporation;
Exelixis Inc.;
GlaxoSmithKline;
Pfizer Inc.

None

None

None

2/6/2014

Richard B. Wilder, MD

None

None

None

None

8/13/2013